Versione delle 20:12, 20 feb 2008 modifica Inviaggio (discussione \| contributi) Utenti autoverificati 24 861 modifiche →‎Fonti bibliografiche: sistemo la bibliografia ← Differenza precedente		Versione delle 20:12, 20 feb 2008 modifica annulla Inviaggio (discussione \| contributi) Utenti autoverificati 24 861 modifiche m →‎Fonti bibliografiche Differenza successiva →
Riga 18: == Fonti bibliografiche == Piraino PS et al: ''Spontaneous remyelination following prolonged inhibition of alpha4 integrin in chronic EAE. ''J Neuroimmunol. 2005 Oct;167(1-2):53-63.Click [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16095724&query_hl=7&itool=pubmed_docsum here] to read ~~''J Neuroimmunol. 2005 Oct;167(1-2):53-63.Click [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16095724&query_hl=7&itool=pubmed_docsum here] to read~~ Yednock TA et al: ''Alpha 4 beta 1 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand.''J Biol Chem. 1995 Dec 1;270(48):28740-50. Click [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=7499396&query_hl=11&itool=pubmed_docsum here] to read *Kleinschmidt-DeMasters BK et al: ''Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis''. N Engl J Med. 2005 Jul 28;353(4):369-74. Epub 2005 Jun 9. Click [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=15947079&query_hl=21&itool=pubmed_docsum here] to read

Natalizumab: differenze tra le versioni